QualityStocksNewsBreaks – B2Digital Inc. (BTDG) Secures Fully Reporting Status with SEC

B2Digital (OTC: BTDG) is now fully reporting after its recent filing of a Form 8-A Registration Statement with the U.S. Securities and Exchange Commission (“SEC”). An article discussing the company reads, “‘We believe that becoming a fully reporting company subject to the reporting requirements of the SEC shows our commitment to providing current public information to not only our deserving and valued shareholders but to the public, in general,’ B2Digital chairman and CEO Greg P. Bell stated in a news release. ‘Being a fully reporting company with the SEC should also help contribute to increased liquidity for our current and future shareholders and will enhance management’s accountability.’ . . . The SEC filing means that BTDG is now subject to the reporting requirements of the Exchange Act of 1934 as amended, including Form 10-K, Form 10-Q and Form 8-K reporting requirements, as well as additional reporting obligations related to proxies, shareholder actions and stock ownership.”

To view the full article, visit http://ibn.fm/OBjaJ

About B2Digital Inc.

With extensive background in entertainment, television, video and technology, B2Digital (OTC: BTDG) is now forging ahead and becoming a full-service, live-event sports company. Capitalizing on the combination of B2Digital CEO Greg P. Bell’s expertise and involvement with more than 40,000 live events over his career for major sports leagues and entertainment venues, B2Digital is in the process of developing and acquiring MMA and sports-related companies to build an integrated premier development league for the multibillion-dollar mixed martial arts (“MMA”) industry. B2Digital intends to create and develop league champions who will move on to the MMA major leagues from the company’s B2 Fighting Series brand. Each year, the top fighters will be invited to the yearly B2 Fighting Series national championship live event. B2Digital has deployed its B2 Social Media Network (“B2SN”) digital distribution network for the B2 Fighting Series and has developed and deployed the systems and technologies for the operation of social-media marketing, event management, digital ticketing sales, digital video distribution, digital marketing, PPV, fighter management, merchandise sales, brand management and financial-control systems. B2Digital owns all rights for TV, internet, social media, media, merchandising and trademarks and branding for the B2Digital companies. For more information, visit the company’s website at www.B2DigitalOTC.com.

NOTE TO INVESTORS: The latest news and updates relating to BTDG are available in the company’s newsroom at http://ibn.fm/BTDG

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Wonderfilm Media Corp. (TSX.V: WNDR) (OTCQB: WDRFF) Appoints PCG Advisory as Investor-Relations, Strategic-Communications Advisor

Wonderfilm Media (TSX.V: WNDR) (OTCQB: WDRFF) is a producer of high-quality feature films and episodic television with international appeal. An article discussing the company reads, “Earlier in October, Wonderfilm appointed PCG Advisory Inc., a leading investor-relations and digital-strategies firm, to serve as an advisor for its investor-relations and strategic communications. The change in IR advisors reflects new market-driven opportunities for Wonderfilm resulting from the unprecedented worldwide appetite for streamed media content (http://ibn.fm/ISmPz).”

To view the full article, visit http://ibn.fm/F7EEP

About Wonderfilm Media

Wonderfilm is a leading, publicly traded entertainment company with offices in Los Angeles and Vancouver, British Columbia. Wonderfilm’s main business is the production of high-quality feature films and episodic television. Global Content Creation leaders — the Wonderfilm team — has packaged, produced and delivered hundreds of profitable films with proven direct access to Academy Award Quality films and upside. For more information, visit the company’s website at www.Wonderfilm.com.

NOTE TO INVESTORS: The latest news and updates relating to WDRFF are available in the company’s newsroom at http://ibn.fm/WDRFF

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Proprietary Drug-Delivery System Featured in Peer-Reviewed Medical Journal

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug-delivery platforms, recently announced that results of a 2018 clinical study evaluating the use of its proprietary drug-delivery system have been published in the peer-reviewed medical journal Advances in Therapy. (http://ibn.fm/PfnAA). An article discussing the company reads, “In its report, Advances in Therapy also referenced a second study published recently by a separate group of researchers that evaluated a comparable CBD dose with bioabsorption findings representative of the cannabinoid-edibles industry sector in general. The results indicate that the rate of bioabsorption of the CBD from the competitive 100 mg formulation was virtually nondetectable within 30 minutes of administration, whereas the TurboCBD 90 mg dose delivered as much drug at 30 minutes as the competitor formulation required nearly 2.5 hours to achieve.”

To view the full article, visit http://ibn.fm/Rt2fE

About Lexaria Bioscience Corp.

Lexaria Bioscience Corp. is a global innovator in drug-delivery platforms. Its patented DehydraTECH(TM) drug-delivery technology changes the way active pharmaceutical ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bioabsorption, reduces time of onset and masks unwanted tastes for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (“NSAIDs”), nicotine and other molecules. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products, as well as to a world-leading tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria operates a licensed, in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Seeks National Impact with National Marketing Campaign, Online CBD-Gummies Sale

• PLUS is utilizing a diverse, multichannel campaign strategy to gain national awareness
• The company is marketing to 43 states with online sales of its PLUS hemp-CBD-infused gummies products
• Plus Products also announced high-profile branding partnerships with celebrity John Legend and Casper Sleep Inc.

Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) is pursuing multiple channel marketing strategies to achieve a national profile. PLUS has also launched its first commercial, digitally available directly to consumers (http://ibn.fm/ocBGW).

The campaign features new PLUS hemp-CBD products, which consumers can purchase online and have shipped to them in 43 states (http://ibn.fm/owZUU). In addition, the company is raising its profile by brand partnering with celebrity John Legend and with direct-to-consumer sleep company Casper Sleep (http://ibn.fm/DD7vI). Legend will be an advocate on behalf of the PLUS CBD line while Casper co-developed the new PLUS line of SLEEP gummies.

The company’s recent launch event in New York City received widespread media coverage in print publications, internet sites, and on-air reports. PLUS received some 300 million impressions from the coverage by Forbes, CNBC, Politico, the Hollywood Reporter, and Billboard. PLUS defines impressions as the number of times a piece or pieces of digital media render on a user’s screen, the company said (http://ibn.fm/Dli81).

The new direct-to-consumer commercial is a key part of PLUS’s campaign to drive awareness with the omni-channel campaign, which includes video advertising and home-page takeovers. A version of the company’s first commercial, with the theme “Find Your Just Right,” is lifestyle driven and features PLUS CBD-infused gummies products.

“The primary goal of our national hemp CBD launch is to put PLUS gummies into as many hands as possible, and this campaign underscores that,” PLUS CEO and co-founder Jake Heimark stated in a news release.

PLUS seeks to leverage its sales dominance in California, where its cannabis-infused edibles are sold by more than 360 licensed retailers statewide. Heimark noted that PLUS has the no. 1 and no. 2 best-selling products across all categories—and the company is well-positioned for continued growth.

For more information, visit the company’s website at www.PlusProducts.com

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://ibn.fm/PLPRF

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Moves to CBD Space Prominence, Products Already Available at 800+ Locations

• The company is aiming to expand its presence domestically and internationally with its recent launch on the Canadian market
• Wildflower Brands’ online CBD store recorded 300 percent growth year over year, with 39 percent of monthly sales coming from repeat customers
• The lucrative U.S. CBD market is estimated to reach $22 billion by 2022

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF), a public cannabis company developing brands that focus on plant-based wellness and health products, is quickly expanding its market presence and looks intent to dominate the CBD space by providing premium branded products through a distribution network comprising of more than 800 locations, as well as a successful online store, according to an October 2019 investor presentation (http://ibn.fm/7LAUv).

Operating out of Washington State, the company markets its CBD products to retailers in the health and wellness space under the slogan “Plants Heal.” Its distribution network in the U.S. includes 200+ retailers in Washington State and 20+ retailers in New York City. In partnership with Retail Worx, the company has established shop-in-shop retail locations in the center of New York City, which complement the introduction of their products at Bridges General’s stores in New York City and San Francisco. Apart from the full range of CBD products marketed under the Wildflower Wellness brand, Wildflower by Bridges General stores will have several exclusive product offerings.

Wildflower products are available in over 260 Dillard’s department stores (http://ibn.fm/5Sox3), as well as at 100 Earthbound Trading locations nationwide, 20 premium health and wellness stores throughout Manhattan, and wellness guru Joel Warren’s Saks Fifth Avenue salon (http://ibn.fm/CMB5p). The company recently completed the strategic acquisition of Canadian-based City Cannabis Corp, which gives it access to four retail stores in Vancouver, British Columbia. Two of these stores were opened in August 2019 (http://ibn.fm/6Wwqe).

Overseas, Wildflower has already completed its first commercial export to the U.K and has started selling its products at high-end retailer Selfridges. Additionally, the company has signed a distribution agreement to begin selling in Poland and is undergoing a packaging compliance processing in Italy. Wildflower also expects to send its first shipment of products to South Africa in early November 2019.

In terms of online sales, the company receives an average of 900 orders per month and achieved a 3.44 percent conversion rate in October 2019. Its online store boasts 39 percent of monthly sales from repeat customers and a growth rate of 300 percent year over year.

These developments, paired with the company’s commitment to delivering only high-quality wellness-focused CBD infused products to the discerning consumer, have had a positive impact on Wildflower’s sales figure. According to the October 2019 investor presentation, the company’s retail sales went up 156 percent year over year. In 2019, Wildflower issued shares worth $136.9 million, options of $10.9 million ($0.20-$1.55), and warrants of $15.2 million ($0.75-$2.25).

Wildflower remains focused on its strategy to expand into large retail chains and launch new products both in the U.S. and internationally. As part of the company’s domestic expansion plans, a 10,000-square-foot manufacturing facility to be completed in November is expected to significantly boost production.

These moves position Wildflower Brands for sustained growth and market prominence in the ever-growing cannabis and CBD space. Analysts anticipate the U.S. CBD market to reach $22 billion by 2022 (http://ibn.fm/hhlfP), while the cannabis market as a whole to top $75 billion by 2030 (http://ibn.fm/ldiK9). The CBD market compound annual growth rate (CAGR) is expected to more than double and reach 107 percent by 2023 (http://ibn.fm/pUAwZ).

For more information, visit the company’s website at www.WildflowerBrands.co

NOTE TO INVESTORS: The latest news and updates relating to WLDFF are available in the company’s newsroom at  http://ibn.fm/WLDFF

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Endonovo Therapeutics Inc. (ENDV) Announces Reverse Stock Split

Endonovo Therapeutics (OTCQB: ENDV), a commercial-stage developer of noninvasive Electroceutical(R) therapeutic devices, on Thursday announced its filing of a preliminary information statement with respect to a proposed reverse stock split of its common stock at a ratio of between 1 for 100 and 1-for-1,000. According to the update, the proposed reverse stock split effectiveness is contingent upon final SEC clearance of the Information Statement, mailing of the statement and a twenty-day waiting period, Endonovo’s sole director’s decision as to the final ratio of the reverse stock split, filing of a certificate of amendment to the company’s certificate of incorporation, and review of the proposal by FINRA. “This reverse stock split is an important step in our future and our goal for growing the company and creating long-term shareholder value and attracting a broader, more diverse shareholder base, especially in light of the SofPulse(R) sales and our national rollout,” Endonovo Therapeutics CEO Alan Collier said in the news release.

To view the full press release, visit http://ibn.fm/6l2M3

About Endonovo Therapeutics

Endonovo Therapeutics is a commercial-stage developer of noninvasive, wearable Electroceuticals(R) therapeutic devices. The company’s current portfolio of commercial and clinical-stage wearable Electroceuticals(R) therapeutic devices addresses wound healing, pain, postsurgical pain and edema, cardiovascular disease, chronic kidney disease, and central nervous system (“CNS”) disorders including traumatic brain injury (“TBI”), acute concussions, post concussion syndrome and multiple sclerosis. The company’s noninvasive Electroceutical(R) therapeutic device, SofPulse(R), which uses pulsed short-wave radiofrequency at 27.12 MHz, has been FDA cleared and CE marked for the palliative treatment of soft-tissue injuries and postoperative pain and edema and has CMS national coverage for the treatment of chronic wounds. The company’s current portfolio of preclinical-stage Electroceuticals(R) therapeutic devices addresses chronic kidney disease, liver-disease nonalcoholic steatohepatitis (NASH), cardiovascular and peripheral artery disease (PAD), and ischemic stroke. The company’s noninvasive, wearable Electroceuticals(R) therapeutic devices work by restoring key electrochemical processes that initiate anti-inflammatory and growth-factor cascades necessary for healing to occur. For more information, visit the company’s website at www.Endonovo.com.

NOTE TO INVESTORS: The latest news and updates relating to ENDV are available in the company’s newsroom at http://ibn.fm/ENDV

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – SinglePoint, Inc. (SING) CEO Discusses Hemp Cigarettes on MoneyTV with Donald Baillargeon

Technology and investment company SinglePoint (OTCQB: SING) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The program is syndicated internationally and covers money-focused topics, featuring various companies and in-depth interviews with CEOs and executives that offer insights into operations and future outlooks. MoneyTV is viewed in over 200 million households in more than 75 countries. This week’s program featured SinglePoint CEO Greg Lambrecht as he discussed the company’s recent endeavor into the hemp cigarette space. “This hemp cigarette business is really going to be huge,” SinglePoint CEO Greg Lambrecht stated in the interview.

To view the full interview, visit http://ibn.fm/Grtqd

To view the full press release, visit http://ibn.fm/hegAn

About SinglePoint Inc.

SinglePoint is a technology and investment company with a focus on acquiring companies that will benefit from the injection of growth capital and technology integration. The company portfolio includes mobile payments, ancillary cannabis services and blockchain solutions. Through acquisitions into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued companies, thereby providing a rich, diversified holding base. Through SingleSeed, the company is providing products and services to the cannabis industry. For more information, visit the company’s website at www.SinglePoint.com.

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://ibn.fm/SING

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php